KSPM
Search
- Page Path
- HOME > Search
Special Article
- Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination
- Nathalie Brunner, Philip Bruggmann
- J Prev Med Public Health. 2021;54(4):251-258. Published online June 24, 2021
- DOI: https://doi.org/10.3961/jpmph.21.151
- 4,265 View
- 120 Download
- 21 Crossref
-
Abstract
PDF - Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or tuberculosis. Today, simple detection methods, highly effective and easy to administer therapies and efficient preventative measures are available to combat hepatitis C. Nevertheless, in most countries around the world, the World Health Organization target of eliminating this infectious disease and its consequences by 2030 are not being met. Significant gaps in care for hepatitis C sufferers still exist, the shortcomings ranging from education and treatment to aftercare. Hepatitis C infection was and still is not on the radar of most politicians and health authorities. National programmes and strategies to combat the disease exist or are being developed in many countries. However, for these to be implemented efficiently and successfully, clear political commitment, strong civil society actors, well-functioning public health structures and the relevant support from global donors are needed.
-
Summary
Citations
Citations to this article as recorded by
- Opportunities and challenges for the application of artificial intelligence paradigms into the management of endemic viral infections: The example of Chronic Hepatitis C Virus
Ahmed N. Farrag, Ahmed M. Kamel, Iman A. El‐Baraky
Reviews in Medical Virology.2024;[Epub] CrossRef - Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit
Shelley J Walker, Lok B Shrestha, Andrew R Lloyd, Olivia Dawson, Yumi Sheehan, Julia Sheehan, Nonso B C Maduka, Joaquin Cabezas, Matthew J Akiyama, Nadine Kronfli
International Journal of Drug Policy.2024; 126: 104386. CrossRef - Metagenomic Detection of Divergent Insect- and Bat-Associated Viruses in Plasma from Two African Individuals Enrolled in Blood-Borne Surveillance
Gregory S. Orf, Ana Olivo, Barbara Harris, Sonja L. Weiss, Asmeeta Achari, Guixia Yu, Scot Federman, Dora Mbanya, Linda James, Samuel Mampunza, Charles Y. Chiu, Mary A. Rodgers, Gavin A. Cloherty, Michael G. Berg
Viruses.2023; 15(4): 1022. CrossRef - Gastrointestinal tract and viral pathogens
Gowthami Sai Kogilathota Jagirdhar, Yashwitha Sai Pulakurthi, Himaja Dutt Chigurupati, Salim Surani
World Journal of Virology.2023; 12(3): 136. CrossRef - Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016–2021; A multi-centre cross-sectional study
Yvonne Ayerki Nartey, Rafiq Okine, Atsu Seake-Kwawu, Georgia Ghartey, Yaw Karikari Asamoah, Ampem Darko Jnr Siaw, Kafui Senya, Amoako Duah, Alex Owusu-Ofori, Opei Adarkwa, Seth Agyeman, Sally Afua Bampoh, Lindsey Hiebert, Henry Njuguna, Neil Gupta, John W
PLOS ONE.2023; 18(6): e0287580. CrossRef - Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis C
Anna Kleczka, Bogdan Mazur, Krzysztof Tomaszek, Andrzej Gabriel, Radosław Dzik, Agata Kabała-Dzik
Diagnostics.2023; 13(13): 2187. CrossRef - Rapid and sensitive LAMP/CRISPR-powered diagnostics to detect different hepatitis C virus genotypes using an ITO-based EG-FET biosensing platform
Hsin-Ying Ho, Wei-Sin Kao, Piyush Deval, Chia-Yen Dai, Yen-Hsu Chen, Ming-Lung Yu, Che-Hsin Lin, Ling-Shan Yu
Sensors and Actuators B: Chemical.2023; 394: 134278. CrossRef - Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer prevention
Spencer Goble, Angelo Z. Mattos, Manuel Mendizabal, Jose D. Debes
Annals of Hepatology.2023; 28(6): 101149. CrossRef - Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey
Karthik Gnanapandithan, Maged P. Ghali, Yury E. Khudyakov
PLOS ONE.2023; 18(10): e0293315. CrossRef - The Prevalence of Transfusion-Transmitted Diseases Among Blood Donors in the Central Blood Bank in Makkah, Saudi Arabia
Mohammad Albshri, Palanisamy Manikandan, Mamdouh Allahyani, Abdulelah Aljuaid, Mazen M Almehmadi, Kamal Alzabeedi, Mohamed Babalgaith, Mosa Alghamdi, Faris Alharbi, Mohammed Alhazmi
Cureus.2023;[Epub] CrossRef - Assessment of the influence of vitamin D level on the course of chronic hepatitis C in comorbidity with chronic pancreatitis
M.A. Derbak, O.V. Buchok, T.M. Ganych, O.A. Rishko, V.V. Timashev
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(7): 478. CrossRef - Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea
Ghirmay Ghebrekidan Ghebremeskel, Michael Berhe Solomon, Oliver Okoth Achila, Samuel Tekle Mengistu, Rahel Frezghi Asmelash, Araia Berhane Mesfin, Mohammed Elfatih Hamida
Scientific Reports.2023;[Epub] CrossRef - DYNAMICS IN MAIN CLINICAL AND IMMUNOLOGICAL INDICATORS IN PATIENTS WITH COMORBIDITY OF CHRONIC HEPATITIS C AND CHRONIC PANCREATITIS FOLLOWING INTEGRATED THERAPY INCLUDING VITAMIN D
M.A. Derbak, O.V. Buchok, O.O. Boldizhar, O.A. Rishko, M.M. Bletskan
Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії.2023; 23(4): 84. CrossRef - PECULIARITIES OF THE FUNCTIONAL STATE OF THE LIVER IN PATIENTS WITH CHRONIC HEPATITIS C IN THE PRESENCE OF CHRONIC PANCREATITIS
Mariya A. Derbak, Olha V. Buchok, Taras M. Ganich, Mariya V. Rivis, Yana V. Lazur, Viktoriya M. Polyak-Tovt, Volodymyr V. Timashev
Wiadomości Lekarskie.2023; 76(11): 2359. CrossRef - Impact of the direct acting antivirals on chronic hepatitis C prevalence on the Swiss organ transplantation list: a retrospective analysis
Luis Falcato, Simone Temperli, Philip Bruggmann, Franz Immer
Exploration of Digestive Diseases.2023; 2(6): 297. CrossRef - ВИВЧЕННЯ ЕФЕКТИВНОСТІ ВІТАМІНУ D В СКЛАДІ КОМПЛЕКСНОЇ ТЕРАПІЇ ХРОНІЧНОГО ГЕПАТИТУ С ПОЄДНАНОГО З ХРОНІЧНИМ ПАНКРЕАТИТОМ
Ольга Бучок , М. Дербак
Grail of Science.2023; (34): 360. CrossRef - Impact of the direct acting antivirals on chronic hepatitis C prevalence on the Swiss organ transplantation list: a retrospective analysis
Luis Falcato, Simone Temperli, Philip Bruggmann, Franz Immer
Exploration of Digestive Diseases.2023;[Epub] CrossRef - THE EFFECT OF COMPLEX THERAPY INCLUDING VITAMIN D ON THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC HEPATITIS C COMBINED WITH CHRONIC PANCREATITIS
M. A. Derbak, O. V. Buchok, O. O. Boldizhar, M. M. Bletskan, V. V. Svistak
Bulletin of Problems Biology and Medicine.2023; 1(2): 166. CrossRef - Intrafamilial transmission risk factors and preventive measures followed by household contacts of hepatitis C patients
Amala Abdulla Saad Ahmed, Saneya Mohamed Rizk, Nabila Abdel-Kader Abdeldaiem
Egyptian Nursing Journal.2023; 20(2): 159. CrossRef - Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program
Paul G. Carty, Conor Teljeur, Cillian F. De Gascun, Paddy Gillespie, Patricia Harrington, Aiden McCormick, Michelle O’Neill, Susan M. Smith, Mairin Ryan
Value in Health.2022; 25(12): 1947. CrossRef - Oncogenic viruses, cancer biology, and innate immunity
Maria C White, Xinjun Wu, Blossom Damania
Current Opinion in Immunology.2022; 78: 102253. CrossRef
First
Prev
